Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Francesca Stufano"'
Autor:
Paola Colpani, Luciano Baronciani, Francesca Stufano, Giovanna Cozzi, Marco Boscarino, Maria Teresa Pagliari, Eugenia Biguzzi, Flora Peyvandi
Publikováno v:
Research and Practice in Thrombosis and Haemostasis. 7:100139
Autor:
Luciano Baronciani, Paola Colpani, Marco Boscarino, Paolo Bucciarelli, Francesca Stufano, Flora Peyvandi, Maria Teresa Pagliari
Publikováno v:
Haemophilia. 26:298-305
Introduction von Willebrand disease (VWD) diagnosis starts with first level tests: factor VIII coagulant activity, VWF antigen (VWF:Ag) and platelet-dependent VWF activity (VWF:RCo, VWF:Ab, VWF:GPIbR or VWF:GPIbM). The VWF collagen binding (VWF:CB) a
Autor:
Anne Goodeve, Philipp Westhofen, Francesca Stufano, Holger Seidel, Karen J. Goodfellow, Annette E. Bowyer, Michael Makris, Stephen Kitchen
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Background\ud The phenotypic diagnosis of von Willebrand disease (VWD) is a multistep process with classification dependent on the quantification of von Willebrand factor (VWF) multimeric structure. VWF multimer analysis is a technically challenging,
Autor:
Maria Teresa Pagliari, Antonino Cannavò, Marcin M. Gorski, Matteo Corgiolu, Ilaria Mancini, Francesca Stufano, Frits R. Rosendaal, Flora Peyvandi, Maria Rosaria Fasulo, Eugenia Biguzzi, Maria Abbattista
Publikováno v:
Journal of Thrombosis and Haemostasis, 16(1), 125-130
Essentials ISTH Bleeding Assessment Tool (ISTH-BAT) is used to assist the diagnosis of bleeding disorders. We examined whether the ISTH-BAT is capable of predicting the risk of future bleeding. 136 subjects were administered the ISTH-BAT and followed
Autor:
G. Cozzi, Luciano Baronciani, Paola Colpani, Eugenia Biguzzi, Flora Peyvandi, Marta Chisini, Francesca Stufano
Publikováno v:
Haemophilia. 25:e30-e32
Autor:
Alberto Maino, Flora Peyvandi, Marco Boscarino, Francesca Stufano, Paolo Bucciarelli, Luciano Baronciani, G. Cozzi
Publikováno v:
Seminars in thrombosis and hemostasis. 45(1)
An increased von Willebrand factor propeptide (VWFpp) to VWF antigen (VWF:Ag) ratio (VWFpp/VWF:Ag) indicates an enhanced clearance of VWF. This finding has been described in von Willebrand disease (VWD) and in acquired von Willebrand syndrome (AVWS).
Autor:
Simona Maria Siboni, Flora Peyvandi, Luciano Baronciani, Paola Colpani, Maria Teresa Pagliari, Francesca Stufano
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 24(4)
Autor:
I. Garcia-Oya, Franca Franchi, Luciano Baronciani, G. Cozzi, Paolo Bucciarelli, Marco Boscarino, Flora Peyvandi, Francesca Stufano, Maria Teresa Pagliari
Publikováno v:
Journal of Thrombosis and Haemostasis. 13:1806-1814
Summary Background Diagnosis of von Willebrand disease (VWD) type 2 usually relies on the discrepancy between the von Willebrand factor (VWF) ristocetin cofactor activity (VWF:RCo) and VWF antigen (VWF:Ag). Type 2B patients can be discriminated from
Autor:
Maria Teresa Pagliari, Luciano Baronciani, Flora Peyvandi, Eugenia Biguzzi, S. La Marca, F. R. Rosendaal, C. Mistretta, Paolo Bucciarelli, Francesca Stufano, Simona Maria Siboni, Maria Teresa Canciani
Publikováno v:
Journal of Thrombosis and Haemostasis, 13(2), 228-236
Summary Background In individuals with borderline von Willebrand factor (VWF) plasma levels, second-level tests are required to confirm or exclude von Willebrand disease (VWD). These tests are time-consuming and expensive. Objective To assess which p
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 24(1)
Introduction Laboratory diagnosis of von Willebrand disease (VWD) is made by the measurement of von Willebrand factor (VWF) protein level and its activities. Current VWF activity tests include ristocetin cofactor and collagen binding (VWF:CB) assays.